EF-6555

N/A

Report date: 2024/12/18 13:39:48
NME

Base Information

Drug NameEF-6555
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionAdvanced glycation end product inhibitors
TargetsAdvanced glycation end product
Therapy Area/IndicationsDiabetic NephropathiesDiabetic Neuropathies
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryJapan
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesMeiji Seika Kaisha Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesMeiji Seika Kaisha Ltd
Active IndicationsN/A
Inactive IndicationsDiabetic NephropathiesDiabetic Neuropathies

Other Information

ATC CodeN/A
Related LinksN/A